Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 20642862)

1.

Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009.

Goldstein E, Cowling BJ, O'Hagan JJ, Danon L, Fang VJ, Hagy A, Miller JC, Reshef D, Robins J, Biedrzycki P, Lipsitch M.

BMC Infect Dis. 2010 Jul 20;10:211. doi: 10.1186/1471-2334-10-211.

2.

Transmission of Norovirus within Households in Quininde, Ecuador.

Gastañaduy PA, Vicuña Y, Salazar F, Broncano N, Gregoricus N, Vinjé J, Chico M, Parashar UD, Cooper PJ, Lopman B.

Pediatr Infect Dis J. 2015 Jun 18. [Epub ahead of print]

PMID:
26090575
3.

Impact of Intensive Handwashing Promotion on Secondary Household Influenza-Like Illness in Rural Bangladesh: Findings from a Randomized Controlled Trial.

Ram PK, DiVita MA, Khatun-E-Jannat K, Islam M, Krytus K, Cercone E, Sohel BM, Ahmed M, Rahman AM, Rahman M, Yu J, Brooks WA, Azziz-Baumgartner E, Fry AM, Luby SP.

PLoS One. 2015 Jun 11;10(6):e0125200. doi: 10.1371/journal.pone.0125200. eCollection 2015.

4.

High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients.

Welch SC, Lam SW, Neuner EA, Bauer SR, Bass SN.

Intensive Care Med. 2015 Jul;41(7):1365-6. doi: 10.1007/s00134-015-3816-z. Epub 2015 May 8. No abstract available.

PMID:
25952823
5.

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.

Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, Arkinstall R, Kelso A, Mcvernon J, Barr IG, Middleton D, Hurt AC.

J Antimicrob Chemother. 2014 Sep;69(9):2458-69. doi: 10.1093/jac/dku146. Epub 2014 May 19.

6.

Pandemic H1N1 virus transmission and shedding dynamics in index case households of a prospective Vietnamese cohort.

Thai PQ, Mai le Q, Welkers MR, Hang Nle K, Thanh le T, Dung VT, Yen NT, Duong TN, Hoa le NM, Thoang DD, Trang HT, de Jong MD, Wertheim H, Hien NT, Horby P, Fox A.

J Infect. 2014 Jun;68(6):581-90. doi: 10.1016/j.jinf.2014.01.008. Epub 2014 Feb 1.

7.

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.

Fry AM, Goswami D, Nahar K, Sharmin AT, Rahman M, Gubareva L, Azim T, Bresee J, Luby SP, Brooks WA.

Lancet Infect Dis. 2014 Feb;14(2):109-18. doi: 10.1016/S1473-3099(13)70267-6. Epub 2013 Nov 22.

PMID:
24268590
8.

Household transmission of influenza A and B in a school-based study of non-pharmaceutical interventions.

Azman AS, Stark JH, Althouse BM, Vukotich CJ Jr, Stebbins S, Burke DS, Cummings DA.

Epidemics. 2013 Dec;5(4):181-6. doi: 10.1016/j.epidem.2013.09.001. Epub 2013 Sep 26.

PMID:
24267874
9.

Factors associated with household transmission of pandemic (H1N1) 2009 among self-quarantined patients in Beijing, China.

Zhang D, Liu W, Yang P, Zhang Y, Li X, Germ KE, Tang S, Sun W, Wang Q.

PLoS One. 2013 Oct 18;8(10):e77873. doi: 10.1371/journal.pone.0077873. eCollection 2013.

10.
11.

[Clinical characteristics and molecular epidemiology of the novel influenza A (H1N1) infection in children in Shanghai].

Wang XS, Cai JH, Yao WL, Ge YL, Zhu QR, Zeng M.

Zhonghua Er Ke Za Zhi. 2013 May;51(5):356-61. Chinese.

PMID:
23941842
12.

Estimated impact of aggressive empirical antiviral treatment in containing an outbreak of pandemic influenza H1N1 in an isolated First Nations community.

Xiao Y, Patel Z, Fiddler A, Yuan L, Delvin ME, Fisman DN.

Influenza Other Respir Viruses. 2013 Nov;7(6):1409-15. doi: 10.1111/irv.12141. Epub 2013 Jul 23.

PMID:
23879801
13.

Virological self-sampling to monitor influenza antiviral susceptibility in a community cohort.

Lackenby A, Elliot AJ, Powers C, Andrews N, Ellis J, Bermingham A, Thompson C, Galiano M, Large S, Durnall H, Fleming D, Smith G, Zambon M.

J Antimicrob Chemother. 2013 Oct;68(10):2324-31. doi: 10.1093/jac/dkt203. Epub 2013 Jun 12.

14.

Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.

Dixit R, Khandaker G, Ilgoutz S, Rashid H, Booy R.

Infect Disord Drug Targets. 2013 Feb;13(1):34-45. Review.

PMID:
23675925
15.

Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses.

Pollara CP, Piccinelli G, Rossi G, Cattaneo C, Perandin F, Corbellini S, Tomasi DD, Bonfanti C.

BMC Infect Dis. 2013 Mar 7;13:127. doi: 10.1186/1471-2334-13-127.

16.

Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): a systematic review.

Mizumoto K, Nishiura H, Yamamoto T.

Theor Biol Med Model. 2013 Jan 16;10:4. doi: 10.1186/1742-4682-10-4. Review.

17.

Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.

Ryoo SM, Kim WY, Sohn CH, Seo DW, Oh BJ, Lee JH, Lee YS, Lim KS.

Influenza Other Respir Viruses. 2013 Sep;7(5):833-7. doi: 10.1111/irv.12065. Epub 2012 Dec 26.

PMID:
23279949
18.

Estimation of outbreak severity and transmissibility: Influenza A(H1N1)pdm09 in households.

House T, Inglis N, Ross JV, Wilson F, Suleman S, Edeghere O, Smith G, Olowokure B, Keeling MJ.

BMC Med. 2012 Oct 9;10:117. doi: 10.1186/1741-7015-10-117.

19.

Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.

Carrat F, Duval X, Tubach F, Mosnier A, Van der Werf S, Tibi A, Blanchon T, Leport C, Flahault A, Mentré F; BIVIR study group.

Antivir Ther. 2012;17(6):1085-90. doi: 10.3851/IMP2128. Epub 2012 Jun 7.

PMID:
22910171
20.

Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.

Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A, Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F, Van Der Werf S, Lina B.

Antiviral Res. 2012 Nov;96(2):130-7. doi: 10.1016/j.antiviral.2012.08.002. Epub 2012 Aug 14.

PMID:
22909899
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk